Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 2
1985 5
1986 8
1987 22
1988 27
1989 22
1990 45
1991 36
1992 70
1993 129
1994 176
1995 188
1996 200
1997 206
1998 211
1999 190
2000 188
2001 174
2002 162
2003 118
2004 114
2005 114
2006 128
2007 122
2008 142
2009 115
2010 118
2011 137
2012 112
2013 99
2014 102
2015 93
2016 77
2017 67
2018 71
2019 95
2020 81
2021 49
2022 26
2023 26
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

3,920 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "AIDS-related disorder"
Page 1
Memantine for dementia.
McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, Maayan N, Ware J, Debarros J. McShane R, et al. Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD003154. doi: 10.1002/14651858.CD003154.pub6. Cochrane Database Syst Rev. 2019. PMID: 30891742 Free PMC article.
SELECTION CRITERIA: Double-blind, parallel group, placebo-controlled, randomised trials of memantine in people with dementia. DATA COLLECTION AND ANALYSIS: We pooled and analysed data from four clinical domains across different aetiologies and severities of dementia …
SELECTION CRITERIA: Double-blind, parallel group, placebo-controlled, randomised trials of memantine in people with dementia. DATA CO …
Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients.
Cillóniz C, Dominedò C, Álvarez-Martínez MJ, Moreno A, García F, Torres A, Miro JM. Cillóniz C, et al. Expert Rev Anti Infect Ther. 2019 Oct;17(10):787-801. doi: 10.1080/14787210.2019.1671823. Epub 2019 Oct 4. Expert Rev Anti Infect Ther. 2019. PMID: 31550942 Free article. Review.
The data discussed here were mainly obtained from a non-systematic review using Medline and references from relevant articles including randomized clinical trials, meta-analyses, observational studies and clinical reviews. Expert opinion: The growing incidenc …
The data discussed here were mainly obtained from a non-systematic review using Medline and references from relevant articles including r
Single High Dose of Liposomal Amphotericin B in Human Immunodeficiency Virus/AIDS-Related Disseminated Histoplasmosis: A Randomized Trial.
Pasqualotto AC, Lana DD, Godoy CSM, Leitão TDMJS, Bay MB, Damasceno LS, Soares RBA, Kist R, Silva LR, Wiltgen D, Melo M, Guimarães TF, Guimarães MR, Vechi HT, de Mesquita JRL, Monteiro GRG, Adenis A, Bahr NC, Spec A, Boulware DR, Israelski D, Chiller T, Falci DR. Pasqualotto AC, et al. Clin Infect Dis. 2023 Oct 13;77(8):1126-1132. doi: 10.1093/cid/ciad313. Clin Infect Dis. 2023. PMID: 37232940 Free PMC article. Clinical Trial.
RESULTS: A total of 118 subjects were randomized, and median CD4+ counts, and clinical presentations were similar between arms. ...CONCLUSIONS: One day induction therapy with 10 mg/kg of L-AmB in AIDS-related histoplasmosis was safe. Although clinic
RESULTS: A total of 118 subjects were randomized, and median CD4+ counts, and clinical presentations were similar between arms …
HIV-associated Hodgkin lymphoma.
Carbone A, Gloghini A, Serraino D, Spina M. Carbone A, et al. Curr Opin HIV AIDS. 2009 Jan;4(1):3-10. doi: 10.1097/COH.0b013e32831a722b. Curr Opin HIV AIDS. 2009. PMID: 19339934 Review.
Recent advances in combined therapies, which are beginning to show promise in the treatment of this HIV-associated disorder, are discussed....
Recent advances in combined therapies, which are beginning to show promise in the treatment of this HIV-associated disorder, are disc …
Odynophagia/dysphagia in AIDS.
Raufman JP. Raufman JP. Gastroenterol Clin North Am. 1988 Sep;17(3):599-614. Gastroenterol Clin North Am. 1988. PMID: 3049365 Review.
Further investigation can be reserved for patients who do not respond to this trial or who have clinical evidence suggesting another esophageal disorder. ...Because of the increasing numbers of patients with AIDS, frequency of esophageal disorders, suc …
Further investigation can be reserved for patients who do not respond to this trial or who have clinical evidence suggesting a …
Immunodeficiency-associated lymphoproliferative disorders.
Knowles DM. Knowles DM. Mod Pathol. 1999 Feb;12(2):200-17. Mod Pathol. 1999. PMID: 10071343 Review.
Non-Hodgkin's lymphoma (NHL) is the second most common AIDS-related neoplasm and an AIDS-defining illness. AIDS-related NHLs are divisible by anatomic site of origin into systemic (nodal/extra nodal), primary central nervous system, and body cavity-bas …
Non-Hodgkin's lymphoma (NHL) is the second most common AIDS-related neoplasm and an AIDS-defining illness. AIDS-rela
AIDS-related lymphoproliferative disease.
Navarro WH, Kaplan LD. Navarro WH, et al. Blood. 2006 Jan 1;107(1):13-20. doi: 10.1182/blood-2004-11-4278. Epub 2005 Aug 11. Blood. 2006. PMID: 16099881 Free article. Review.
Not long after the recognition of HIV as the causative agent of AIDS, it was evident that individuals infected with HIV developed lymphoma at a greater rate than the population at large. Approximately two thirds of AIDS-related lymphoma (ARL) cases are categorized a …
Not long after the recognition of HIV as the causative agent of AIDS, it was evident that individuals infected with HIV developed lymphoma a …
HIV/AIDS-related cardiovascular disease.
Chaves AA, Mihm MJ, Basuray A, Baliga R, Ayers LW, Bauer JA. Chaves AA, et al. Cardiovasc Toxicol. 2004;4(3):229-42. doi: 10.1385/ct:4:3:229. Cardiovasc Toxicol. 2004. PMID: 15470271 Review.
This brief review provides an overview of the significance and complexities of HIV/ AIDS-related cardiovascular complications and addresses some important mechanistic aspects that may contribute to this important clinical problem....
This brief review provides an overview of the significance and complexities of HIV/ AIDS-related cardiovascular complications …
HIV: new drugs, new guidelines.
Geretti AM, Tsakiroglou M. Geretti AM, et al. Curr Opin Infect Dis. 2014 Dec;27(6):545-53. doi: 10.1097/QCO.0000000000000106. Curr Opin Infect Dis. 2014. PMID: 25304395 Review.
For years, efavirenz-based ART was favoured by treatment guidelines, reflecting unsurpassed performance in clinical trials. New treatment options show high efficacy and safety and include single-tablet coformulations for once-daily dosing to improve convenience. ...SUMMARY …
For years, efavirenz-based ART was favoured by treatment guidelines, reflecting unsurpassed performance in clinical trials. New treat …
Atovaquone: a review.
Haile LG, Flaherty JF. Haile LG, et al. Ann Pharmacother. 1993 Dec;27(12):1488-94. doi: 10.1177/106002809302701215. Ann Pharmacother. 1993. PMID: 8305784 Review.
Limited data exist on the use of atovaquone for toxoplasmic encephalitis (TE); however, results from an open trial reveal that the drug may be useful in treating this disorder. ...There is not enough information available on the use of atovaquone for PCP prophylaxis …
Limited data exist on the use of atovaquone for toxoplasmic encephalitis (TE); however, results from an open trial reveal that the dr …
3,920 results